Pendal Group LTD Biogen Inc. Transaction History

Pendal Group LTD

$12.2 Billion
Q4 2022

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 18, 2022	BUY	$194.69 - $268.46 $1.84 Million - $2.53 Million	9,429 Added 210.23%	13,914 $3.72 Million
Q2 2022 Jul 25, 2022	SELL	$187.54 - $223.02 $500,356 - $595,017	-2,668 Reduced 37.3%	4,485 $915,000
Q1 2022 Apr 25, 2022	BUY	$193.77 - $244.14 $796,588 - $1 Million	4,111 Added 135.14%	7,153 $1.51 Million
Q4 2021 Jan 18, 2022	BUY	$223.92 - $287.77 $360,063 - $462,734	1,608 Added 112.13%	3,042 $730,000
Q3 2021 Nov 05, 2021	SELL	$282.99 - $369.05 $29,430 - $38,381	-104 Reduced 6.76%	1,434 $406,000
Q2 2021 Jul 28, 2021	SELL	$259.0 - $414.71 $3.06 Million - $4.9 Million	-11,805 Reduced 88.47%	1,538 $533,000
Q1 2021 May 24, 2021	BUY	$242.95 - $284.63 $3.24 Million - $3.8 Million	13,343 New	13,343 $3.73 Million
Q1 2021 May 03, 2021	SELL	$242.95 - $284.63 $3.13 Million - $3.67 Million	-12,897 Closed	0 $0
Q4 2020 Jan 21, 2021	SELL	$236.26 - $355.63 $3.34 Million - $5.02 Million	-14,116 Reduced 52.26%	12,897 $3.16 Million
Q3 2020 Nov 02, 2020	SELL	$264.77 - $305.71 $2.12 Million - $2.45 Million	-8,025 Reduced 22.9%	27,013 $7.66 Million
Q2 2020 Aug 07, 2020	BUY	$258.66 - $342.55 $3.31 Million - $4.38 Million	12,780 Added 57.42%	35,038 $9.38 Million
Q1 2020 May 04, 2020	SELL	$268.85 - $341.04 $6.96 Million - $8.82 Million	-25,873 Reduced 53.76%	22,258 $7.04 Million
Q4 2019 Feb 06, 2020	SELL	$220.06 - $304.07 $5.66 Million - $7.82 Million	-25,729 Reduced 34.83%	48,131 $14.3 Million
Q3 2019 Nov 12, 2019	SELL	$217.44 - $243.88 $5.59 Million - $6.27 Million	-25,718 Reduced 25.83%	73,860 $17.2 Million
Q2 2019 Aug 01, 2019	BUY	$219.29 - $241.72 $461,605 - $508,820	2,105 Added 2.16%	99,578 $0
Q1 2019 May 01, 2019	BUY	$216.71 - $338.96 $8.76 Million - $13.7 Million	40,443 Added 70.92%	97,473 $0
Q4 2018 Jan 30, 2019	SELL	$278.5 - $352.75 $2.86 Million - $3.63 Million	-10,282 Reduced 15.28%	57,030 $17.2 Million
Q3 2018 Nov 05, 2018	BUY	$293.51 - $383.83 $6.02 Million - $7.87 Million	20,513 Added 43.83%	67,312 $0
Q2 2018 Jul 18, 2018	BUY	$257.52 - $306.91 $585,342 - $697,606	2,273 Added 5.1%	46,799 $0
Q1 2018 May 08, 2018	SELL	$260.13 - $367.91 $528,584 - $747,593	-2,032 Reduced 4.36%	44,526 $0
Q4 2017 Feb 06, 2018	BUY	$307.64 - $344.58 $1.39 Million - $1.56 Million	4,520 Added 10.75%	46,558 $0
Q3 2017 Nov 01, 2017	SELL	$281.15 - $329.69 $385,737 - $452,334	-1,372 Reduced 3.16%	42,038 $0
Q2 2017 Aug 11, 2017	BUY	N/A	43,410	43,410 $0

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pendal Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pendal Group LTD with notifications on news.

Account